Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Given the significance of S -palmitoylation in cancer, the DHHCs and protein depalmitoylases are promising targets for cancer therapy
Our online pharmacist is available Monday to Friday, 8am-4pm (AWST): Phone: 1800 418 429 SMS: +61 483 913 912 Email: [email protected]
It contains 1.5 mL of semaglutide solution at a concentration that delivers either 0.25 mg or 0.5 mg per injection
J.FrancisD.OliverN.et al (2018)
Medical Dialogues / DCGI Approval Notice CDSCO Approved BMI Thresholds DCGI has approved semaglutide for obesity in adults with BMI 30 kg/m, or BMI 27 kg/m with at least one weight-related comorbidity (hypertension, T2D, dyslipidaemia, or sleep apnea)
Patients were randomized to TRESIBA once-daily in the evening or insulin glargine U-100 once-daily according to the approved labeling
US$ 28.22
US$ 24.52
US$ 20.77
US$ 27.26
US$ 27.64
US$ 20.86
US$ 25.07
US$ 28.00
US$ 28.17
US$ 29.00
US$ 29.83
US$ 27.51
US$ 25.40
